Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 3
2017 5
2018 4
2019 4
2020 5
2021 2
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
[Management of Cast Nephropathy].
De Simone E, Fenoglio R, Cortazzi S, Careddu A, Geraci G, Bugliosi F, Sciascia S, Roccatello D. De Simone E, et al. G Ital Nefrol. 2023 Oct 3;40(Suppl 81):2023-S81. G Ital Nefrol. 2023. PMID: 38007838 Review. Italian.
Antiphospholipid Syndrome and Kidney Involvement.
De Simone E, Sciascia S, Fenoglio R, Oddone V, Barreca A, Roccatello D. De Simone E, et al. Kidney Blood Press Res. 2023;48(1):666-677. doi: 10.1159/000529229. Epub 2023 Sep 21. Kidney Blood Press Res. 2023. PMID: 37734329 Free article. Review.
Daratumumab monotherapy for refractory lupus nephritis.
Roccatello D, Fenoglio R, Caniggia I, Kamgaing J, Naretto C, Cecchi I, Rubini E, Rossi D, De Simone E, Del Vecchio G, Cozzi M, Sciascia S. Roccatello D, et al. Among authors: de simone e. Nat Med. 2023 Aug;29(8):2041-2047. doi: 10.1038/s41591-023-02479-1. Epub 2023 Aug 10. Nat Med. 2023. PMID: 37563241 Free PMC article.
Clinical-Pathological Characteristics of Renal Injuries Identify Different Clusters in Patients With Antiphospholipid Antibodies.
Sciascia S, Yazdany J, Moroni G, Becker JU, Seshan SV, Andrade D, Emmi G, Cuadrado MJ, Radin M, Cecchi I, De Simone E, Barreca A, Caroti L, Innocenti S, Fenoglio R, Roccatello D. Sciascia S, et al. Among authors: de simone e. Kidney Int Rep. 2023 Jan 23;8(4):754-763. doi: 10.1016/j.ekir.2023.01.018. eCollection 2023 Apr. Kidney Int Rep. 2023. PMID: 37069974 Free PMC article.
Treating Patients With ANCA-Associated Vasculitis and Very Severe Renal Injury With an Intensified B Cell Depletion Therapy: Comparison With a Control Cohort Receiving a Conventional Therapy.
Roccatello D, Sciascia S, Murgia S, Quattrocchio G, Ferro M, De Simone E, Naretto C, Barreca A, Sammartino A, Rossi D, Fenoglio R. Roccatello D, et al. Among authors: de simone e. Front Immunol. 2022 Mar 24;13:777134. doi: 10.3389/fimmu.2022.777134. eCollection 2022. Front Immunol. 2022. PMID: 35401565 Free PMC article.
New Onset Biopsy-Proven Nephropathies after COVID Vaccination.
Fenoglio R, Lalloni S, Marchisio M, Oddone V, De Simone E, Del Vecchio G, Sciascia S, Roccatello D. Fenoglio R, et al. Among authors: de simone e. Am J Nephrol. 2022;53(4):325-330. doi: 10.1159/000523962. Epub 2022 Mar 30. Am J Nephrol. 2022. PMID: 35354140 Free PMC article.
Management of acute kidney injury in frail patients with biopsy-proven cast nephropathy: a combined approach with chemotherapy plus Supra-hemodiafiltration with post-adsorption endogenous reinfusion.
Murgia S, Quattrocchio G, Forneris G, Pozzato M, Fenoglio R, Ferro M, De Simone E, Del Vecchio G, Di Benedetto C, Roccatello D. Murgia S, et al. Among authors: de simone e. J Nephrol. 2022 May;35(4):1243-1249. doi: 10.1007/s40620-021-01226-4. Epub 2022 Jan 4. J Nephrol. 2022. PMID: 34982413
The Challenging Management of Cancer: An Immunonephrologist's Perspective.
Fenoglio R, Roccatello D, De Simone E, Del Vecchio G, Ferro M, Quattrocchio G, Barreca A, Sciascia S. Fenoglio R, et al. Among authors: de simone e. Kidney Blood Press Res. 2021;46(1):114-120. doi: 10.1159/000511256. Epub 2020 Dec 16. Kidney Blood Press Res. 2021. PMID: 33326976 Free article.
28 results